Prostate-Specific Antigen Test Market Size

Report ID: GMI7136
   |
Published Date: October 2023
 | 
Report Format: PDF

Download Free PDF

Prostate-Specific Antigen Test Market Size

Prostate-Specific Antigen Test Market size was valued at USD 3.9 billion in 2022 and is estimated to reach around USD 8.8 billion by 2032. The ongoing research in the field of prostate cancer diagnostics and therapy has resulted in the development of more advanced  testing and prostate cancer treatment devices. These advancements increase the effectiveness of Prostate-specific antigen (PSA) testing for early detection and monitoring.

 

Prostate-Specific Antigen Test Market

Furthermore, with the aging population expanding and the notable prevalence of prostate cancer among older males, it is anticipated that the market will experience substantial growth in the coming years. According to a publication in the World Journal of Oncology, prostate cancer affects approximately 1 in 350 males under the age of 50, with the incidence rate increasing to 1 in every 52 men between the ages of 50 and 59. Among men over the age of 65, the incidence rate soars to nearly 60%. As the elderly population continues to grow, there will be a rising number of individuals at an elevated risk of prostate cancer. Consequently, this will lead to an increased demand for PSA testing.

 

The prostate-specific antigen test is a diagnostic blood test that quantifies the bloodstream's concentration of PSA, a protein secreted by the prostate gland.

 

Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the eminent prostate-specific antigen test industry players?
Abbott Laboratories Inc., AdvaCare Pharma, Bayer AG, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., GE HealthCare, Abcam plc., Lomina AG, and Laboratory Corporation of America Holdings are some of the major prostate-specific antigen test companies.
What factors are driving North America prostate-specific antigen test market growth?
What is the prostate-specific antigen test market worth?
How are hospitals influencing the prostate-specific antigen test industry?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2022

    Companies covered: 10

    Tables & Figures: 340

    Countries covered: 21

    Pages: 200

    Download Free PDF

    Top